FDA panel narrowly backs wider peptide access despite safety concerns

The Food and Drug Administration's Pharmacy Compounding Advisory Committee is grappling with the use of peptides, compounds popular with wellness influencers and celebrities. On Thursday, the panel narrowly recommended easing access to several of these substances, a decision made despite significant warnings from government scientists.

“

This is really alarming. There aren't that many other substances people are injecting into themselves where you see that the clinical evidence is so lacking.

These scientists have cautioned that the chemicals have not been proven safe or effective. Nevertheless, the compounds are widely promoted on social media, with users sharing testimonials about benefits ranging from muscle building and injury recovery to anti-aging effects. Figures like podcaster Joe Rogan and wellness influencer Gary Brecka, a proponent of Health Secretary Robert F. Kennedy Jr.'s "Make America Healthy Again" agenda, are among the prominent supporters.

Health Secretary Robert F. Kennedy Jr. himself has expressed strong support for peptides, vowing to overturn industry restrictions previously put in place. However, the FDA's two-day meeting has highlighted a stark division over the compounds. Career FDA scientists maintain that insufficient data exists to justify wider availability, particularly from compounding pharmacies which create customized medicines.

“

big fan

Adding to the controversy, the advisory panel includes at least seven doctors or pharmacists with financial connections to the peptide industry. These individuals have ties to wellness clinics selling peptides, pharmacies producing them, and online businesses promoting them. While the FDA has added experts without industry ties, the potential for conflicts of interest has drawn criticism, mirroring concerns raised about other expert panels appointed under Kennedy.

“

Make America Healthy Again